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Background: Although high on treatment platelet reactivity (HTPR) is an important predictor of clinical outcomes in patients undergoing coronary 
stenting, it is unknown whether endothelial dysfunction and HTPR are associated. We examined the platelet function, peripheral vascular function, 
endothelial progenitor cell (EPC) number, platelet activation markers, high-sensitivity C-reactive protein (hsCRP) and clinical outcomes in patients 
receiving chronic clopidogrel therapy.
methods: We consecutively enrolled 91 patients who underwent follow-up angiography because of chest discomfort. All patients took aspirin and 
clopidogrel for an average of 498 ± 138 days. Platelet reactivity was assessed by light transmittance aggregometry [maximal platelet aggregation 
by 5 μmol/L of adenosine diphosphate ≤50% in Group 1 (optimal response) and >50% as Group 2 (HTPR)]. Flow-mediated dilation (FMD) of the 
brachial artery and brachial-ankle pulse wave velocity (PWV), numbers of EPCs isolated from peripheral blood, platelet activation markers (sCD40L 
and sP-selectin) and hsCRP were assessed before follow-up angiography.
results: There were no significant differences in baseline characteristics and previous percutaneous coronary intervention (PCI) data between 
Group 1 (n=59) and 2 (n=32). Group 2 showed poorer FMD (6.1±4.1 vs. 12.9±6.2%, p<0.001), PWV (1925.4±362.2 vs. 1571.0 ±306.5 ms, 
p<0.001) and lower circulating EPCs by flow cytometry (21.9±14.7/10fields vs. 65.2±30.1/10fields, p<0.001) compared with Group 1. Significantly 
higher levels of sCD40L, sP-selectin and hsCRP were observed in Group 2. In multivariate analysis, elevated hsCRP, but not HTPR, was independently 
associated with repeated PCI.
conclusions:  In patients with angina, HTPR was associated endothelial dysfunction and elevated hsCRP, although elevated hsCRP level was 
significantly associated with poorer outcomes.
